iPothecary Investors

Investment Thesis

Building the product infrastructure
for specialty healthcare.

iPothecary connects product data, inventory, retail, safety, and traceability across eye-care practices — creating the foundation for a connected product lifecycle from manufacturer to patient.

Connected infrastructure

Lifecycle visibility

One record

The Problem

Specialty practices manage products with fragmented infrastructure.

Specialty practices increasingly recommend and sell products directly to patients — but the operational infrastructure surrounding those products is poorly connected. A practice may use one system for purchasing, another for checkout, spreadsheets for inventory, email for recalls, and vendor portals for product information.

That fragmentation is fundamentally a data and infrastructure problem — not simply a workflow inconvenience.

Vendor portals
Manufacturer catalogs
Spreadsheets
POS systems
Accounting systems
Physical counts
Email
Staff knowledge
Product documentation
Recall communications
These systems know
pieces of the story.
Inventory visibility

No single source of truth across locations

Working capital

Overstock, expiration, and write-off exposure

Safety response

Manual recall matching without traceability

Retail performance

No structured transaction-to-product data

Multi-location consistency

Different products, prices, and policies by site

Patient continuity

No link between recommendation and purchase

The Platform

One lifecycle instead of disconnected transactions.

iPothecary is not replacing a POS. It is connecting the entities that surround a transaction — from source to safety.

Source Manufacturer / Vendor
Understand Product / Package / Docs
Receive Lot / Expiration / Inventory
Operate Locations / Transfers
Sell Recommendation / Checkout
Protect Recall / Safety / Traceability
Retain Repeat Purchase / Autoship
Roadmap

Current Platform

What exists today.

The current foundation centers on connected product, inventory, safety, and practice operations. Expansion items are separated clearly below.

Product Catalog

  • Structured product catalog
  • Manufacturer and vendor records
  • Product documentation
  • Identifiers and package information

Inventory Operations

  • Multi-location inventory
  • Receiving and stock movement
  • Lot and batch tracking
  • Expiration monitoring
  • Cycle counts and discrepancy resolution

Safety & Recall

  • Recall and safety information
  • Product-to-lot matching
  • Affected inventory identification
  • Hold and response workflows
  • Safety document management

Retail & Commerce

  • Practice-selected products
  • In-office kiosk retail
  • Staff-assisted checkout
  • Transaction history
  • Location-aware retail activity

Practice Operations

  • Multi-location organization support
  • Roles and permissions
  • Operational reporting
  • Device and label management
  • Practice administration
  • Audit history

Expansion Path

Start with operations. Expand across the lifecycle.

Phase 1 Current

Product Operations

  • Structured product catalog
  • Multi-location inventory
  • Vendor management
  • In-office retail
  • Safety and recall workflows
Phase 2 In Progress

Product Intelligence

  • Deeper manufacturer integrations
  • Product documentation
  • Advanced ordering workflows
  • Vendor relationship management
  • Product availability intelligence
Phase 3 Roadmap

Patient Continuity

  • Practice-branded online purchasing
  • Repeat ordering
  • Home delivery
  • Autoship / replenishment
  • Patient purchase history
Phase 4 Roadmap

Network Infrastructure

  • Manufacturer connectivity
  • Distribution partnerships
  • Product launch infrastructure
  • Practice-vendor network effects
  • Product performance intelligence

Vertical Selection

Why eye care.

Start where clinical recommendation and product purchasing already overlap naturally. Eye care is characterized by chronic conditions, high rates of physician-recommended product usage, and multi-location specialty practice organizations — all within an existing vendor and manufacturer ecosystem that currently lacks connected infrastructure.

  • Chronic conditions driving repeat product demand
  • Physician-recommended OTC and specialty categories
  • Significant multi-location practice organizations
  • Fragmented retail and inventory operations
  • High patient trust and clinical recommendation authority
  • Active vendor and manufacturer relationships

Eye care is the initial wedge — not necessarily the ceiling.

Market Timing

Why now.

Practice consolidation

Larger multi-location organizations require centralized systems with local execution capability.

Consumerization of healthcare

Patients increasingly expect convenient access to products recommended by their providers.

Product complexity

Practices manage more manufacturers, vendors, lots, documentation, and safety events than ever before.

Margin pressure

Ancillary revenue and operational efficiency are increasingly important to practice economics.

Infrastructure maturity

APIs, payment platforms, and healthcare interoperability make connectivity increasingly possible.

Strategic Infrastructure

The transaction is only one moment in the product lifecycle.

Recall and traceability create a reason for the underlying data model to exist independently of commerce. A manufacturer issues a recall. Without lifecycle connectivity, a practice must manually determine: whether they carry the product, which locations have it, which lots are present, what has been sold, and which patient transactions may need review.

With iPothecary, product, lot, location, inventory, transaction, and customer relationships can exist within one operational system. Safety creates the infrastructure reason — retail is one monetization layer on top of it.

Without lifecycle connectivity
  • Which locations carry it?
  • Which lots are on-hand?
  • What has already sold?
  • Which patient transactions need review?
  • Is affected stock removed?

Answered manually, inconsistently, or not at all.

With iPothecary
  • Product → location relationship exists
  • Lot → inventory link is recorded
  • Transactions are connected to lots
  • Relevant transactions can be reviewed
  • Quarantine can be triggered systematically

Answered from the operational record.

Business Model

How iPothecary can make money.

Revenue streams reflect the natural progression of platform depth.

Current model

SaaS Platform

Practice subscriptions based on organization size, locations, and capability tier. The primary recurring revenue mechanism.

Current model

Transaction Revenue

A platform fee associated with eligible retail transactions processed through iPothecary-connected payment workflows.

Prospective

Manufacturer & Vendor

Commercial relationships involving product onboarding, practice access, integrations, and data products where legally appropriate.

Prospective

Fulfillment & Recurring Commerce

Revenue associated with direct-to-patient transactions, repeat ordering, autoship, and fulfillment partnerships as the platform expands.

Prospective

Implementation & Services

Onboarding, hardware, integration, and professional services revenue associated with practice deployment and setup.

Competitive Position

Defensibility emerges from the connected data model.

The software is not the moat. The depth of the connected record is.

Product graph

Relationships between product, manufacturer, vendor, package, lot, location, inventory, transaction, and safety event — held together in one operational record.

Workflow depth

iPothecary becomes embedded in receiving, inventory, retail, recall, and daily operations — not serving as a dashboard over existing workflows.

Historical lifecycle data

Operational history accumulates value over time. A practice that has managed three years of inventory, recalls, and transactions has something that cannot easily be transferred.

Multi-location standardization

Once organizations build standardized product operations around a platform, switching costs increase significantly — particularly for organizations with centralized purchasing.

Network potential

As practices, manufacturers, vendors, and product data become more connected, each side benefits from participation by the others. iPothecary can develop a two-sided ecosystem.

Safety and compliance requirement

Traceability and recall workflows are not optional features — they are operational requirements. Infrastructure that addresses them becomes structurally necessary.

Economic Engine

The business compounds with each connected entity.

More Practices

Create demand and transaction activity

More Locations

Expand the operational footprint

More Products Managed

Deepen the product graph

More Transactions

Increase lifecycle data density

More Product Lifecycle Data

Increase manufacturer and vendor value

Stronger Manufacturer Value

Deepen product integrations and partnerships

Better Platform Value

Attract more practices

iPothecary has the potential to develop a two-sided ecosystem connecting specialty practices with the manufacturers and vendors supplying the products they recommend.

Traction

Early validation in a real clinical environment.

Development is grounded in live specialty practice operations — real staff workflows, multi-location inventory, vendor relationships, and safety requirements — rather than hypothetical design.

Multi-location
Anchor practice with locations across a regional market
Live
Inventory, retail, and recall workflows in active use
Full stack
Product catalog through transaction — one integrated system
Real workflows
Built around actual staff operations, not assumed ones

Detailed metrics including active locations, products managed, GMV, ARR, and pipeline are available to qualified investors in a controlled conversation.

Market Opportunity

A bottom-up framework.

Rather than citing a top-down market figure, the relevant question is how many specialty practices can benefit from connected product lifecycle infrastructure, and what that is worth per organization.

Target specialty practices
×
Locations per organization
×
Annual platform revenue per location
+
Transaction revenue
+
Manufacturer and vendor revenue
=
Addressable market

Expansion Path

Eye care as a wedge.

Eye care is an attractive initial vertical — but it is a wedge, not necessarily a ceiling. The product lifecycle problem exists across specialty medicine wherever clinical recommendation and product purchasing naturally overlap.

Eye Care Initial vertical — active development
Dermatology Physician-recommended product workflows
Aesthetic Medicine Complex vendor and product relationships
Other Specialty Healthcare Where clinical recommendation drives product purchasing

Expansion into additional specialties is not an immediate commitment. Eye care provides the operational foundation first.

Team

Built from inside the workflow.

iPothecary is being built by people with direct experience inside multi-location specialty eye-care organizations — not by an engineering team that studied the industry from the outside.

Healthcare practice operations
Multi-location eye-care environment
Clinical technology
Enterprise software development
Product, vendor, and inventory workflows
Healthcare interoperability
Retail and payment infrastructure
Regulatory and compliance workflows
"Built from inside the workflow rather than from outside healthcare looking in."

Detailed team biographies are available in the investor conversation.

Long-Term Vision

The infrastructure connecting products,
practices, and patients.

The company does not need to own every part of the supply chain. The opportunity is to become the software layer connecting it.

Today
Tangible operational value: inventory, product information, safety, recall, retail.
As adoption grows
Increasingly embedded in product operations across multiple locations.
As product relationships expand
Practices, manufacturers, and vendors connected through the platform.
As commerce expands
Direct purchasing, repeat ordering, autoship.
Long term
The product lifecycle infrastructure for specialty healthcare.

Investor Relations

Interested in the future of product infrastructure
in specialty healthcare?

We're interested in speaking with investors and strategic partners who understand healthcare operations, vertical software, commerce infrastructure, or specialty medicine.

Detailed information — financial statements, cap table, forecasts, customer contracts, and pipeline — is available in a controlled investor conversation, not on this page.

Contact

Start a controlled investor conversation.

Use the contact form and select investor relations so your request reaches the right conversation.

Go to the contact form